BHATT PADMANABH P. (Sr. VP of IP, CSO) sold 48.3% of their position (9.48K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $376.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0001628280-25-004073
Officer· Sr. VP of IP, CSO
Since Feb 2026
-9.48K
Net shares
Net seller
$376.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.48K acquired · 18.95K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.48K
Price / share
$29.61
Trade value
$280.61K
% of position
93.4%
2/4/2025
10.15K→19.63K
Common Stock
Direct
Shares
−9.48K
Price / share
$39.70
Trade value
$376.24K
% of position
48.3%
2/4/2025
19.63K→10.15K
Total
Net shares
+0.00
Net value
-$95.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | M · Option Exercise | +9.48K | $29.61 | $280.61K | 93.4% | 10.15K | 19.63K |
| Common Stock Direct | 2/4/2025 | S · Sale | −9.48K | $39.70 | $376.24K | 48.3% | 19.63K | 10.15K |
| Total | +0.00 | -$95.62K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.48K shares
Shares
−9.48K
Strike price
29.61
Held after
4.25K
Exercisable
—
2/4/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock9.48K shares | 2/4/2025 | M · Option Exercise | −9.48K | 29.61 | — | 4.25K |